Adaptive Biotechnologies
ADPT
$2.60
Share price
-0.38%
Change (1 day)
-63.59%
Change (1 year)
Categories
P/S ratio for Adaptive Biotechnologies (ADPT)
P/S ratio as of April 2024 (TTM): 2.22
According to Adaptive Biotechnologies 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.21546. At the end of 2023 the company had a P/S ratio of 4.17.
P/S ratio history for Adaptive Biotechnologies from 2019 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 4.17 | -29.34% |
| 2022 | 5.90 | -77.02% |
| 2021 | 25.7 | -68.79% |
| 2020 | 82.2 | 86.63% |
| 2019 | 44.0 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 HCA Healthcare HCA | 1.25 | -43.64% | 🇺🇸 USA |
 Premier PINC | 1.91 | -13.87% | 🇺🇸 USA |
 Community Health Systems
CYH | 0.0377 | -98.30% | 🇺🇸 USA |
 Select Medical Holdings SEM | 0.5280 | -76.17% | 🇺🇸 USA |